After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
West Monroe featured on Benzinga
Date : February 6, 2015

2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

According to Bloomberg data, drug makers announced a record $234 billion in acquisitions last year, nearly triple 2013 volumes.

The year was marked by a string of mega-deals and serial acquirers, from Medtronic's $42.9 billion purchase of medical device manufacturer Covidien multibillion buys of Forest Laboratories and Allergan. Barely a month in to 2015, the industry shows no signs of sweating out the M&A bug.

West Monroe takes a look at the primary drivers behind pharmaceutical and biotech deals in 2014, and what they indicate for M&A over the next twelve months. Click here to view the article as it originally appeared on Benzinga.


What We Might Expect From Changes in the Nation's Capital
View More
Related News
West Monroe Partners adds healthcare expertise to its local office leadership team as strong demand fuels growth.
Author:
Date : January 17, 2017


Industry:
Chris Althoff and Bryan Komornik discuss five ways healthcare providers and insurers can strengthen the patient-provider connection in the height of the digital age.
Date : January 12, 2017
The healthcare customer experience is rooted in the patient-provider connection. A recent Gallup poll found that U.S. citizens rank nurses, pharmacists and doctors as the top three most honest and ethical professions. But while this trust serves as a solid foundation, patient-provider relationships are only as strong as the lines of communication between these two groups.
Industry:
Health care consumers now expect the same type of seamless experience they get from Amazon and Uber
Author:
Date : January 11, 2017

Dan Howell discusses how healthcare organizations can best serve today's highly engaged consumer. 

Industry: